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ABSTRACT
Previous studies have demonstrated a high prevalence of seropositivity to the Ani s 1 protein in
dyspeptic patients with Helicobacter pylori infection, but it is not known whether this represents episodes
of anisakiasis misdiagnosis or previous exposure to the parasite without clinical relevance. To
investigate the clinical signiﬁcance of seropositivity to the Ani s 1 protein, a cohort study was performed
with 87 consecutive dyspeptic patients who were treated for H. pylori infection. Fourteen (16.5%)
patients were seropositive for the Ani s 1 protein, which was associated with the consumption of
uncooked ﬁsh (p 0.0002). There were no differences in histological ﬁndings between subjects
seropositive or seronegative for Ani s 1, but seropositive patients had increased eosinophil and
basophil leukocyte counts (p < 0.05). Anti-Ani s 1 IgE was associated with a lack of improvement in the
group of patients with non-ulcer dyspepsia after successful eradication of H. pylori (p 0.016). Thus, in at
least a subset of patients with H. pylori infection, seropositivity to Ani s 1 could have clinical relevance.
In addition, these data highlight that only anisakiasis associated with severe allergic or gastric
symptoms is currently being diagnosed.
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INTRODUCTION
Anisakis simplex is a nematode that has a world-
wide distribution and is found frequently in a
large variety of ﬁsh consumed by humans. Infec-
tion is caused by eating uncooked ﬁsh or seafood
containing the third-stage larvae of A. simplex.
After ingestion, larvae can penetrate the host
stomach or intestinal wall. The resulting disease,
known as anisakiasis or anisakidosis, can mimic
other gastrointestinal disturbances and allergic
reactions, such as urticaria, angioedema or ana-
phylaxis [1,2]. Fibreoptic gastroscopy within 24 h
of ﬁsh ingestion, or an exploratory laparotomy, is
required for diagnosis when anisakiasis is sus-
pected [1,3]. Therefore, it is suspected that only the
most severe cases requiring invasive techniques
are diagnosed, and that many mild cases remain
unrecognised [4]. Although serological techniques
for the detection of A. simplex infection have been
developed, cross-reactivity with other nematodes
is a serious limitation [5–8]. In an attempt to
improve diagnosis, a major IgE-binding protein
has been puriﬁed from the parasite and charac-
terised. This major parasite allergen, termed
Ani s 1, is a protein from the excretory gland that
shows no homology with other proteins described
previously [9]. Detection of speciﬁc IgE for
Ani s 1 has been shown to be a useful tool for
the diagnosis of anisakiasis [10].
A high prevalence of seropositivity to Ani s 1
has been reported in dyspeptic patients with
Helicobacter pylori infection [11], but the clinical
signiﬁcance of this ﬁnding is unknown. It is
possible that episodes of anisakiasis in combina-
tion with H. pylori infection may have been misdi-
agnosed, or that the ﬁndings may reﬂect previous
exposure to the parasite without clinical relevance.
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The present study investigated whether seroposi-
tivity to Ani s 1 might have a clinical role in this
setting by performing a cohort study in a group of
dyspeptic patients with H. pylori infection.
PATIENTS AND METHODS
Patients
Consecutive dyspeptic patients (n = 87) who underwent a
programmed upper endoscopy and were treated for H. pylori
infection were enrolled in the study. Endoscopy procedures
were performed in the Gastroenterology Unit at Hospital
Carlos III (Madrid, Spain) between February 1998 and
January 1999. Excluded were patients who had been treated
previously to eradicate H. pylori infection, or who had
received antimicrobial or antacid agents during the previous
3 months; patients who were taking non-steroidal anti-
inﬂammatory drugs (including low doses of aspirin) within
a month of endoscopy; and patients with underlying
diseases, gastrointestinal bleeding, documented gastro-oeso-
phageal reﬂux or endoscopic evidence of oesophagitis,
previous gastric surgery, cholelithiasis, or any abnormal
physical and laboratory ﬁndings. The present study was
approved by the Ethics Committee of the Hospital Carlos III,
with informed consent to participate being obtained from
each patient.
Dyspepsia was deﬁned as an intermittent or persistent
pain, or discomfort in the upper abdominal region or lower
part of the chest, heartburn, nausea, a feeling of post-
prandial fullness, or any other symptoms thought to be
related to the upper gastrointestinal tract that lasted for
‡ 3 weeks [12]. Ulceration was diagnosed when there was an
area of complete loss of mucosa > 0.5 cm in diameter.
Erosive duodenitis is considered to be a variant form of
duodenal ulcer, with symptomatic and histological improve-
ment after eradication of H. pylori infection. For these
reasons, this condition was included in the group of ulcer
dyspepsia (UD) conditions [13,14]. Patients with normal
endoscopy ﬁndings (i.e., ﬁve or fewer gastric erosions and
no gastric or duodenal ulcer) were diagnosed with non-ulcer
dyspepsia (NUD) [15].
Data collection
All patients were interviewed with the aid of a standard
questionnaire before endoscopic examination. The ﬁrst part of
the questionnaire was an abbreviated version of the Gastro-
intestinal Symptom Rating Scale, which includes the main
ulcer-like symptoms (abdominal pain, heartburn, acid regur-
gitation and sucking sensations in the epigastrium) and uses
a validated four-point Likert scale [16]. The severity of the
associated symptoms was scored as 0 (absent), 1 (low
intensity), 2 (moderate intensity) or 3 (severe). In addition,
the patients answered questions designed to reveal the
presence of any IgE-mediated diseases (urticaria, angioede-
ma, anaphylactic reactions or other symptoms). Finally,
tobacco and alcohol consumption were recorded as described
previously [11], and the patients were asked about their ﬁsh-
eating habits during the previous year, including the type
and form of consumption (uncooked, i.e., raw or smoked,
and cooked). The patients were classiﬁed, with respect to the
frequency of consumption, as non-consumers or sporadic
consumers (monthly or less) and habitual consumers (more
than once-monthly).
Endoscopy
All patients were examined by upper endoscopy with a
conventional video-endoscope (FG-100FP; Fujinon, Tokyo,
Japan). All endoscopy devices were disinfected with glutar-
aldehyde 2% v ⁄v. During the endoscopy procedure, the
presence of macroscopic lesions in the stomach was evaluated
carefully, and at least ﬁve biopsy samples, three from the
antrum and two from the corpus, were obtained.
H. pylori infection and histology
During endoscopy, biopsy samples were taken for histological
examination (two antrum and two corpus biopsies) and
culture (one antrum biopsy). H. pylori infection was diagnosed
by positive culture and ⁄ or histological results. Neutrophil
inﬁltration, mononuclear cell inﬁltration, glandular atrophy,
intestinal metaplasia and H. pylori density in the gastric biopsy
samples were assessed on a scale of 0–3, in accordance with the
updated Sydney System [17], using formalin-ﬁxed biopsy
tissues stained with haematoxylin–eosin. Eosinophil inﬁltra-
tion was analysed using the same approach. All histological
evaluations were performed by a single pathologist with no
knowledge of the clinical and serological results.
Differential blood counts
At the time of the endoscopy, venous blood samples were
collected in EDTA-treated tubes. Total leukocyte counts were
determined using a Coulter AcT Diff 2 haematology analyser
(Beckman Coulter, Fullerton, CA, USA). Differential blood
counts were made from blood smears stained by Diff-Quik.
Counts were performed by one investigator in a blinded
fashion, and the mean of two slides was calculated (300 cells
counted ⁄ slide).
Determination of Ani s 1-speciﬁc IgE
Sera. At the time of endoscopy, a serum sample was obtained
from each patient and stored at ) 80C. All patients were tested
for the presence of IgE against A. simplex extract. IgE directed
speciﬁcally against Ani s 1 was studied in subjects who were
reactive to the A. simplex extract.
Antigens. The A. simplex extract was prepared with larvae
obtained from muscle tissue of Merluccius merluccius and
Micromesistious poutassou. Larvae (c. 200) were ground in a
mortar with 5 mL of phosphate-buffered saline. After centrif-
ugation for 10 min at 4500 g, the pellet was discarded. The
protein content of the supernatant was 2 mg ⁄mL, as measured
by the Bradford method [18], with bovine serum albumin as
the protein standard. Ani s 1 was isolated from larvae and
puriﬁed from the crude parasite extract by ethanol precipita-
tion and reverse-phase HPLC as described previously [9].
Immunoblotting. Ani s 1 (0.1 mL of a 100 mg ⁄L dilution) or
crude A. simplex extract (0.1 mL of a 1000 mg ⁄L dilution) was
mixed with 0.1 mL of phosphate-buffered saline. The mixture
was electrophoresed (150 V) in an acrylamide 16% w ⁄v mini-
gel with standard SDS-PAGE conditions, and then transferred
by diffusion to two nitrocellulose sheets for 18 h. After being
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blocked in Nonidet P-40 3% v ⁄v for 30 min, the membranes
were placed on a Mini-Protean II multiscreen (Bio-Rad,
Hercules, CA, USA). For speciﬁc IgE determination, the
different sera were diluted 1:6 in incubation buffer (125 mM
Tris, pH 6.8, SDS 4% w ⁄v, glycerol 2% v ⁄v, bromophenol blue
0.042% w ⁄v) and incubated overnight in independent cham-
bers. After incubation and washing, the membranes were
incubated for 3 h with 10 mL of a 1:1000 dilution of a
monoclonal human anti-IgE antiserum (Ingenasa, Madrid,
Spain). After further washes, the membranes were incubated
with 10 mL of a 1:4000 dilution of an alkaline phosphatase-
labelled goat anti-mouse antiserum (Biosource, Camarillo, CA,
USA). Finally, the membranes were washed, and the signal
was visualised by staining with 5-bromo-4-chloro-3-indolyl
phosphate-4-nitroblue tetrazolium (Amresco, Solon, OH, USA)
for 30 min.
Drug administration and follow-up
Patients received either omeprazole 20 mg, amoxycillin
1000 mg and clarithromycin 500 mg, or ranitidine bismuth
citrate 400 mg, amoxycillin 1000 mg and clarithromycin
500 mg, each given twice daily for 1 week. All patients were
reviewed at 2 months after treatment was completed. At this
time, the urea breath test was performed to determine whether
H. pylori had been eradicated. The overall effect of treatment
was assessed by comparing the severity of dyspeptic symp-
toms before and after treatment with the Likert scale. A score
of 0–1 was considered as resolution, while a score of ‡ 2 was
considered to indicate persistence of dyspeptic symptoms.
This cut-off point was assessed by constructing a receiver
operated characteristic curve in which the speciﬁcity was
plotted against 1 minus sensitivity for the full range of post-
treatment dyspepsia scores. All follow-up was performed with
neither the patients nor the interviewer being aware of the
results of the A. simplex serology and recent breath tests, and
whether or not the infection had been eradicated.
Statistical analysis
Categorical variables were analysed with the chi-square test,
Fisher exact test or analysis of variance (ANOVA), as appropri-
ate. Linear regression models were used to compare the
number of blood leukocytes (log-transformed data) between
anti-Ani s 1 IgE-seropositive and -seronegative subjects,
adjusting for age, gender, tobacco and alcohol consumption.
A p value < 0.05 was considered to be signiﬁcant. SPSS v.11
(SPSS Inc., Chicago, IL, USA) was used for all analyses.
RESULTS
Of the 87 patients included in the study, two were
lost to follow-up. The mean age of the 85 patients
studied was 47.4 years (range 21–78 years) and 45
were male. No cases of active parasitism were
diagnosed during endoscopy procedures. How-
ever, anti-Ani s 1 IgE antibodies were detected in
14 (16.5%) of the 85 patients. Twenty-three
(27.1%) patients were habitual consumers of
uncooked ﬁsh, with pickled anchovies being
implicated in 18 (78.3%) patients. There was a
signiﬁcant relationship between seroreactivity to
Ani s 1 and the habitual intake of uncooked ﬁsh
(10 ⁄ 23; p 0.0002). The clinical and epidemiological
features of the patients seropositive for Ani s 1
are shown in Table 1.
Thirty-seven patients showed ulceration by
endoscopy (29 patients with duodenal ulcers,
seven with gastric ulcers, and one with both),
and 48 patients were diagnosed with NUD (37
patients with active chronic gastritis and 15 with
intestinal metaplasia ⁄ atrophy). The distribution
of endoscopy and histological ﬁndings was sim-
ilar for anti-Ani s 1 IgE-seropositive and -sero-
negative patients. In addition, there were no
differences between anti-Ani s 1 IgE-seropositive
and -seronegative subjects with respect to the
grade of eosinophil, neutrophil and mononuclear
cell inﬁltration in biopsy samples (data not
Table 1. Clinical and epidemiological data for the 14 patients positive for IgE against Ani s 1
Patient Gender ⁄ age Dyspepsia
Uncooked ﬁsh consumptiona Dyspepsia after
Helicobacter
pylori eradication Allergy symptomsFrequency Form
1 M ⁄ 50 UD Habitual Smoked No No
2 M ⁄ 48 UD Habitual Pickled No No
3 F ⁄ 61 UD None or sporadic – No No
4 F ⁄ 55 UD Habitual Smoked No Urticaria ⁄ angioedema
5 F ⁄ 50 UD None or sporadic – No No
6 M ⁄ 45 UD Habitual Pickled No No
7 F ⁄ 57 NUD Habitual Pickled ⁄ smoked Yes No
8 F ⁄ 47 NUD Habitual Pickled Yes Urticaria ⁄ angioedema
9 F ⁄ 50 NUD None or sporadic – Yes No
10 M ⁄ 48 NUD Habitual Pickled Yes No
11 F ⁄ 35 NUD Habitual Raw Yes Urticaria ⁄ angioedema
12 M ⁄ 23 NUD Habitual Pickled No No
13 M ⁄ 50 NUD None or sporadic – b No
14 M ⁄ 56 NUD Habitual Pickled ⁄ raw b No
UD, ulcer dyspesia; NUD, non-ulcer dyspepsia; M, male; F, female.
aNon-consumers or sporadic consumers, once or less ⁄month; habitual consumers, more than once ⁄month.
bNo eradication of H. pylori infection.
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shown). However, the total numbers of eosino-
phils and basophils were increased signiﬁcantly
in patients with anti-Ani s 1 IgE antibody, com-
pared with seronegative subjects (p < 0.05). The
histological ﬁndings and blood leukocyte counts
for anti-Ani s 1 IgE-seropositive and -seronega-
tive patients are shown in Table 2.
The validity of the abbreviated version of
Gastrointestinal Symptom Rating Scale was
assessed by comparing the dyspepsia scores in
110 healthy volunteers, 110 patients with NUD,
and 47 patients with a peptic ulcer. The mean
scores in these three groups were 0.32 (range 0–3),
5.8 (1–11), and 5.7 (2–12), respectively. The scores
in the patients with NUD and UD were similar,
and both were signiﬁcantly higher than those in
the healthy control group (p < 0.001).
In the group of 36 patients with UD, all but one
(97.3%) showed successful eradication of H. pylori
infection. The median dyspepsia score at initial
presentation for these 36 subjects was 5.6 (range
2–11). At reassessment, only three (9.1%) had
persistent symptoms (score ‡ 2). Eradication of
H. pylori infection was achieved in 42 (87.5%) of
48 NUD subjects. At endoscopy, the median score
of these 42 subjects was 5.9 (range 2–12). A high
proportion (15 ⁄ 42; 35.7%) of these patients had
persistent symptoms following successful treat-
ment for H. pylori infection, which was a higher
proportion than that observed with the UD group
(p 0.004).
Of the 18 subjects with persistent dyspeptic
symptoms after H. pylori eradication, ﬁve (27.8%)
were positive for anti-Ani s 1. This proportion
was higher than that observed among subjects
whose symptoms had been relieved (7 ⁄ 60;
11.7%), although the difference was not statisti-
cally signiﬁcant. When this analysis was per-
formed only in the subset of subjects with NUD,
anti-Ani s 1 antibodies were signiﬁcantly more
frequent among patients with persistent symp-
toms than among those who had alleviated
symptoms (33.3% vs. 3.7%; p 0.016).
Ten patients reported episodes of urticaria ⁄
angioedema. These allergy symptoms were more
frequent in anti-Ani s 1 IgE-seropositive patients
(3 ⁄ 14; 21.4%) than in seronegative patients (7 ⁄ 71;
9.9%), although the difference was not statisti-
cally signiﬁcant (p 0.357).
DISCUSSION
The present study was performed with a cohort of
dyspeptic patients treated for H. pylori infection.
The enrolment criteria excluded patients who
required an urgent endoscopy in whom anisaki-
asis is usually diagnosed; in fact, no cases of active
parasitism were detected at the time of endo-
scopy. Nevertheless, the observed rate of sero-
positivity to Ani s 1 was high, and was similar to
that reported in a previous more extensive epi-
demiological study [11]. The high seroprevalence
of Ani s 1 IgE in the present study may be caused
by several factors: ﬁrst, Spain has a high level of
ﬁsh consumption (85 g ⁄person per day) [19];
second, a high level of ﬁsh parasitism of ‡ 45%
has been detected, depending on the species
examined [20]; and third, the habitual consump-
tion of uncooked ﬁsh, especially pickled ancho-
vies, was very high.
Endoscopy and histological ﬁndings were asso-
ciated mainly with H. pylori infection, and there
were no differences between anti-Ani s 1 IgE-
seropositive and -seronegative patients. This is to
be expected, as anisakiasis is an infection that is
difﬁcult to diagnose and does not produce ulcers
or major histological changes [21]. Although
intestinal infestation with parasites is a frequent
cause of eosinophilic gastroenteritis, no differ-
ences in eosinophil cell inﬁltration between sero-
positive and seronegative patients were found.
However, the number of biopsy samples obtained
was limited, and eosinophil cell inﬁltration is
restricted mainly to the site at which the larvae
penetrate. Anisakiasis is rarely considered to be a
cause of eosinophil gastritis, despite A. simplex
being a relatively common parasite in ﬁsh [1]. In
contrast, the total numbers of eosinophils and
Table 2. Comparison of histological ﬁndings and blood
leukocyte counts (log-transformed values) between anti-
Ani s 1 IgE-seropositive and -seronegative patients
Anti-Ani s 1 IgE-
positive n = 14
Anti-Ani s 1 IgE-
negative n = 71 p
Histological ﬁndingsa
Ulcer 6 (42.9) 31 (43.7) 0.955
Active chronic gastritis 5 (53.7) 32 (45.1) 0.173
Atrophy ⁄metaplasia 3 (21.4) 8 (11.2) 0.379
Blood leukocyte countb
Total leukocytes 3.87 (3.79–3.97) 3.85 (3.76–3.92) 0.092
Neutrophils 3.67 (3.50–3.77) 3.61 (3.51–3.70) 0.14
Lymphocytes 3.41 (3.35–3.47) 3.41 (3.32–3.48) 0.684
Monocytes 2.70 (2.60–2.78) 2.60 (2.48–2.70) 0.084
Eosinophils 2.21 (0.00–2.62) 0.00 (0.00–2.03) 0.027
Basophils 0.05 (0.00–2.02) 0.00 (0.00–0.00) 0.02
aCategorical data are absolute numbers (%).
bContinuous variables are median (interquartile range) and comparisons were
performed after adjusting for age, gender, tobacco consumption and alcohol intake
by linear regression analysis.
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basophils in blood were increased signiﬁcantly in
patients seropositive for Ani s 1 after adjusting
for variables that can affect the blood leukocyte
count. Both eosinophilia and basophilia are com-
mon in subjects who suffer from anisakiasis [1,22].
All of these data illustrate the limited value of
endoscopy and histological examination in diag-
nosing many cases of this parasitic infestation,
and underline the need to implement serological
approaches.
The persistence of dyspeptic symptoms was
analysed after successful eradication of H. pylori
infection. Most patients experienced symptomatic
relief; however, as reported previously, the clin-
ical beneﬁt was higher among UD patients than
among NUD patients [23–26]. Anti-Ani s 1 IgE
was found signiﬁcantly more frequently among
NUD patients showing a lack of improvement
after successful eradication of H. pylori. It is
noteworthy that anisakiasis is a condition that
is difﬁcult to diagnose and that ulcer formation is
rare [21]. Therefore, the data seem to suggest that
many cases of anisakiasis with mild symptoms
could be misdiagnosed as NUD, but the results
must be interpreted cautiously because of the
limited sample size. More studies are needed to
link therapeutic intervention with clinical
improvement to conﬁrm these results.
Although Ani s 1 is a major allergen of A. sim-
plex, no association was found between detection
of anti-Ani s 1 IgE and allergy symptoms. In
contrast, previous studies have reported the
frequent ﬁnding of IgE-mediated diseases in
patients with anisakiasis [2]. However, this associ-
ation has been described in individuals with a
severe allergic reaction that required urgent
endoscopy. These data could suggest that most
cases of anisakiasis with mild allergic symptoms
remain undiagnosed.
The underlying mechanism of anisakiasis is
based on IgE-mediated reactions [27,28]. Thus, the
development of disease requires previous sensi-
tisation to the parasite. Individuals seropositive
for A. simplex in the present study were regular
consumers of uncooked ﬁsh. Therefore, it can be
hypothesised that these seropositive individuals
may have had previous episodes of anisakiasis.
These episodes would have been indolent, or with
mild allergic or gastric symptoms. It is notewor-
thy that sensitised subjects with repeated expo-
sure to the parasite will be at risk of developing
acute anisakiasis with severe symptoms. This
form of anisakiasis represents the tip of the
iceberg of the disease and constitutes most cases
diagnosed currently.
In conclusion, the results from the present
study seem to suggest that, in at least a subset
of individuals with H. pylori infection, seroposi-
tivity to A. simplex could have clinical signiﬁ-
cance. Laboratory ﬁndings and an accurate
history of ﬁsh-eating habits would be helpful in
identifying possible episodes of anisakiasis with
clinical relevance. These data also highlight the
fact that only cases of anisakiasis causing severe
allergic or gastric symptoms requiring invasive
techniques are currently being diagnosed.
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